Sastasundar ventures Limited has announced a postal ballot seeking shareholder approval for significant corporate changes, including a proposed name change to Health X Platform Limited and amendments to its main object clause. The company has scheduled the e-voting period from January 15, 2026, to February 13, 2026, with results to be declared by February 16, 2026.

Proposed Name Change Details

The company seeks to change its name from Sastasundar Ventures Limited to Health X Platform Limited, reflecting its strategic direction toward health-related businesses and platform-based operations. The Ministry of Corporate Affairs has already reserved the desired name "Health X Platform Limited" for the company through a letter dated January 1, 2026.

The company operates as a Core Investment Company (CIC) with subsidiaries predominantly engaged in healthcare activities. According to the consolidated financial statements for the financial year ended March 31, 2025, the majority of the company's income comes from healthcare activities through its subsidiaries.

E-Voting Schedule and Process

Shareholders can participate in the postal ballot exclusively through electronic voting, as physical ballot forms will not be distributed. The company has appointed Mr. Raj Kumar Banthia, Company Secretary in Practice (Membership No. 17190 and CP No. 18428), as the scrutinizer for conducting the postal ballot process.

Amendments to Main Object Clause

The second resolution proposes amendments to the main object clause of the company's Memorandum of Association by adding two new objects:

• Object 7: To carry on healthcare, beauty care, personal care, pharmaceuticals, wellness, diagnostics, and food business, including manufacturing, processing, marketing, trading, distribution, and related services
• Object 8: To design, develop, own, operate, manage, and maintain digital platforms and e-commerce services, including marketplace operations, trading, order fulfillment, warehousing, logistics, and data management

These additions aim to expand the company's scope to include activities relating to allied healthcare operations while maintaining its existing main objects unchanged.

Regulatory Compliance and Approvals

The company has obtained statutory auditor certification from JKVS & Co., Chartered Accountants, confirming compliance with Regulation 45(1) of the SEBI Listing Regulations. The certification, dated January 7, 2026, validates that:

• At least one year has elapsed since the last name change
• More than fifty percent of total revenue comes from activities suggested by the new name
• The company meets all prescribed conditions for name change

Both resolutions require approval through special resolutions, needing support from shareholders holding at least 75% of the votes cast. The postal ballot notice has been sent electronically to all shareholders whose email addresses are registered with the company or depositories as of the cut-off date of January 9, 2026.

Summary

Sastasundar Ventures Limited's proposed transformation to Health X Platform Limited represents a strategic alignment with its healthcare-focused business operations. The e-voting process from January 15-February 13, 2026, will determine shareholder approval for both the name change and expanded business objectives, positioning the company for enhanced operations in healthcare and digital platform services.

Sastasundar Ventures Limited announced significant corporate restructuring plans following its Board of Directors meeting held on January 7, 2026. The board approved a comprehensive rebranding initiative that includes changing the company name to Health X Platform Limited and expanding its business scope through amendments to the Memorandum of Association.

Board Resolutions and Corporate Changes

The board meeting, which commenced at 3:30 PM and concluded at 4:00 PM, resulted in several key decisions that will reshape the company's identity and operational framework. The directors approved the alteration of the name clause from Sastasundar Ventures Limited to Health X Platform Limited, along with consequential changes to the company's Memorandum and Articles of Association.

Business Scope Expansion

The company plans to significantly expand its operational scope through amendments to the main object clause of its Memorandum of Association. Two new clauses will be inserted after the existing Clause 6 in the Main Object Clause, broadening the company's business activities into multiple sectors.

The first new clause authorizes the company to carry on healthcare, beauty care, personal care, pharmaceuticals, wellness, diagnostics, and food businesses. This includes manufacturing, processing, marketing, trading, distribution, and providing related services, either directly or through subsidiaries.

The second clause enables the company to design, develop, own, operate, manage, and maintain digital platforms and e-commerce services. This encompasses:

• Marketplace operations and trading
• Order fulfillment and warehousing
• Logistics and data management
• Analytics and consumer engagement
• Digital marketing and promotion
• All incidental and ancillary activities

Regulatory Approval Process

The proposed changes are subject to multiple levels of approval to ensure compliance with regulatory requirements. The board has authorized the dispatch of a postal ballot notice to shareholders, with the cut-off date for beneficial position (BENPOS) set for January 9, 2026.

Compliance and Documentation

The board's decisions align with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, ensuring proper regulatory compliance for the proposed amendments. Company Secretary and Compliance Officer Pratap Singh has been authorized to manage the documentation and approval processes.

The comprehensive nature of these changes reflects the company's strategic vision to transform from its current business model into a diversified healthcare and digital platform entity. The rebranding to Health X Platform Limited signals the company's commitment to establishing a strong presence in the healthcare technology sector while maintaining its operational flexibility through subsidiary structures.